Oppenheimer reiterates Nurix stock rating after Roche deal
Oppenheimer reiterates Nurix stock rating after Roche deal
Oppenheimer reiterates Nurix stock rating after Roche deal
Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.